| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,378 | 41,080 | 30,623 | 86,294 | | Cost of Revenue | 30,820 | 32,565 | 28,084 | 56,624 | | | Gross Profit | 3,558 | 8,515 | 2,539 | 29,670 | | | Operating Expenses | | Research Development | 7,217 | 7,020 | 5,849 | 12,041 | | Selling General and Administrative | 12,471 | 11,224 | 10,652 | 10,486 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,130) | (9,729) | (13,962) | 7,143 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 722 | 588 | 441 | 1,558 | | Earnings Before Interest And Taxes | (15,408) | (9,141) | (13,521) | 8,701 | | Interest Expense | 18 | 15 | 14 | 15 | | Income Before Tax | (15,426) | (9,156) | (13,535) | 8,686 | | Income Tax Expense | 256 | (318) | (100) | 19,151 | | Minority Interest | 1,802 | 2,151 |
-
| 2,963 | | | | Net Income From Continuing Ops | (13,880) | (6,687) | (13,435) | (7,502) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,880) | (6,687) | (13,435) | (7,502) | | Preferred Stock And Other Adjustments |
-
| (436) | 436 |
-
| | | Net Income Applicable To Common Shares | ($13,880) | ($7,123) | ($12,999) | ($7,502) |
|
0.51% Nasdaq 
0.01 (0.25%) 
Income Statement
